LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $245,000 | -20.7% | 2,755 | 0.0% | 0.02% | -5.6% |
| Q1 2022 | $309,000 | +6.6% | 2,755 | +46.9% | 0.02% | 0.0% |
| Q4 2021 | $290,000 | +11.1% | 1,876 | 0.0% | 0.02% | +5.9% |
| Q3 2021 | $261,000 | +6.1% | 1,876 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $246,000 | +15.0% | 1,876 | -2.0% | 0.02% | -19.0% |
| Q2 2020 | $214,000 | +7.0% | 1,915 | 0.0% | 0.02% | +16.7% |
| Q4 2019 | $200,000 | -8.7% | 1,915 | 0.0% | 0.02% | -18.2% |
| Q2 2019 | $219,000 | -9.1% | 1,915 | 0.0% | 0.02% | -18.5% |
| Q1 2019 | $241,000 | – | 1,915 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |